Detall de la convocatòria
Característiques
Característica |
---|
Objectiu de la convocatòria
The purpose of this call is to finance research projects that develop strategies, tools, technologies and with the intention of facilitating the development, optimization for surveillance systems and/or diagnosis of antimicrobial resistance. |
Característiques principals
This call aims to improve the treatment of bacterial and fungal infections (including co-infection) and/or the prevention of the emergence/spread of resistance in humans, animals or plants through the improvement of the efficacy, specificity, delivery, combinations and/or repurposing of drugs and plant protection agents. Proposals should focus on licenced antimicrobial agents (antibiotics/antifungals) or agents under pre-clinical and/or early clinical development, and should address at least one of the following topics: Topic 1: to develop novel, or improve existing, diagnostics, including point of care diagnostics, that can rule out antimicrobial use or help identify the most effective antimicrobial treatment. Within this topic projects may: Topic 2: to develop or improve existing strategies, technologies or methods, or data use strategies to support One Health AMR surveillance. Within this topic projects may: Proposals can focus on one or more of the three “One-Health” settings, namely: The following sub-topics are out of scope of the call: |
Lloc de presentació
El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a: Research Grants and Contracts Office. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.05.76. Marta López: mlopez4@imim.es Ext.: 1576 Carol Barnwell: cbarnwell@imim.es Ext.1670 |
Convocatòria (URL)
https://www.jpiamr.eu/calls/diagnostics-surveillance-call-2023/ https://ptoutline.eu/app/jpiamr2023_distomos |
Informació addicional
The call follows a two-stage procedure: |
Requisits
Consortia must include a minimum of three (3) eligible partners asking for funding from three (3) different eligible countries (including at least two amongst EU Member States or Associated Countries). Consortia should consist of a maximum of six (6) project partners (including non-funded partners). The maximum number of partners can be increased to seven (7) if the consortium includes: a) at least one partner from an under-represented country (including LDCs), b) at least one partner where the Principal Investigator meets the definition of an Early Career Researcher, or c) a company. Networks are encouraged to consider gender and geographical diversity among partners. |
Dotació
Up to €180,000/€260,000 for partners/coordinators |
Durada
Funding is granted for a maximum of 3 years in accordance with national regulations and applicable legal provisions. |
AVÍS IMPORTANT
The call is made at European level but each partner of the consortium is funded by its national funding agency and must follow its national funding rules. Spanish participants are funded by ISCIII. There are eligibility requirements for the institutions and principal investigators funded by ISCIII. (please see annex A of the Call text) For Spanish applicants funded by ISCIII: after the evaluation at European level, successful applicants will be invited to submit an application to ISCIII. Due to the complexity of the call, if you are interested in submitting an application we strongly recommend that you contact the Servei de Recerca well in advance of the deadline. |
Arxius
Arxiu |
---|
Call-text_AMR-diagnostics-and-surveillance-2023_v20230116.pdf |
Pre-proposal-form_AMR-diagnostics-and-surveillance-2023.docx |